Ching‐An Peng

1.1k total citations
61 papers, 832 citations indexed

About

Ching‐An Peng is a scholar working on Molecular Biology, Biomedical Engineering and Materials Chemistry. According to data from OpenAlex, Ching‐An Peng has authored 61 papers receiving a total of 832 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 19 papers in Biomedical Engineering and 11 papers in Materials Chemistry. Recurrent topics in Ching‐An Peng's work include RNA Interference and Gene Delivery (11 papers), Virus-based gene therapy research (10 papers) and 3D Printing in Biomedical Research (5 papers). Ching‐An Peng is often cited by papers focused on RNA Interference and Gene Delivery (11 papers), Virus-based gene therapy research (10 papers) and 3D Printing in Biomedical Research (5 papers). Ching‐An Peng collaborates with scholars based in United States, Taiwan and Pakistan. Ching‐An Peng's co-authors include Jin‐Oh You, Chung‐Hao Wang, Young Jik Kwon, Bernhard Ø. Palsson, Yu‐Chuan Liu, Chia‐Wei Chang, Hong Yu, Wen‐Ming Hsu, Gene Hung and W. French Anderson and has published in prestigious journals such as PLoS ONE, Cancer Research and Chemical Communications.

In The Last Decade

Ching‐An Peng

61 papers receiving 809 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ching‐An Peng United States 16 272 252 136 133 80 61 832
Aleš Prokop United States 17 342 1.3× 416 1.7× 184 1.4× 276 2.1× 87 1.1× 48 1.2k
Rosita Primavera United States 16 239 0.9× 306 1.2× 181 1.3× 259 1.9× 51 0.6× 30 935
Shahrouz Taranejoo Iran 13 238 0.9× 276 1.1× 65 0.5× 268 2.0× 42 0.5× 20 798
Dongmei Xu China 12 292 1.1× 146 0.6× 92 0.7× 200 1.5× 43 0.5× 28 647
Jun F. Liang United States 17 302 1.1× 187 0.7× 97 0.7× 238 1.8× 19 0.2× 31 830
Kingshuk Dutta United States 16 376 1.4× 177 0.7× 199 1.5× 288 2.2× 39 0.5× 20 815
Yongsheng Yu China 22 589 2.2× 353 1.4× 125 0.9× 303 2.3× 43 0.5× 56 1.3k
Edikan Archibong United States 9 394 1.4× 577 2.3× 107 0.8× 225 1.7× 40 0.5× 17 1.0k
Changkyu Lee South Korea 16 356 1.3× 314 1.2× 114 0.8× 372 2.8× 55 0.7× 30 902
Chuanxu Yang Denmark 23 676 2.5× 354 1.4× 270 2.0× 389 2.9× 79 1.0× 43 1.5k

Countries citing papers authored by Ching‐An Peng

Since Specialization
Citations

This map shows the geographic impact of Ching‐An Peng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ching‐An Peng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ching‐An Peng more than expected).

Fields of papers citing papers by Ching‐An Peng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ching‐An Peng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ching‐An Peng. The network helps show where Ching‐An Peng may publish in the future.

Co-authorship network of co-authors of Ching‐An Peng

This figure shows the co-authorship network connecting the top 25 collaborators of Ching‐An Peng. A scholar is included among the top collaborators of Ching‐An Peng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ching‐An Peng. Ching‐An Peng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Peng, Ching‐An, et al.. (2024). Eradication of Cancer Cells Using Doxifluridine and Mesenchymal Stem Cells Expressing Thymidine Phosphorylase. Bioengineering. 11(12). 1194–1194. 1 indexed citations
2.
Peng, Ching‐An, et al.. (2024). Extracellular vesicles isolated from Arabidopsis thaliana leaves reveal characteristics of mammalian exosomes. PROTOPLASMA. 261(5). 1025–1033. 18 indexed citations
3.
Peng, Ching‐An, et al.. (2022). Eradication of Myrosinase-Tethered Cancer Cells by Allyl Isothiocyanate Derived from Enzymatic Hydrolysis of Sinigrin. Pharmaceutics. 14(1). 144–144. 8 indexed citations
4.
Lin, Yuan‐Yu, Jon Y. Takemoto, Cheng‐Wei Tom Chang, & Ching‐An Peng. (2022). Mesobiliverdin IXα ameliorates osteoporosis via promoting osteogenic differentiation of mesenchymal stem cells. Biochemical and Biophysical Research Communications. 619. 56–61. 1 indexed citations
5.
Zhang, Jun & Ching‐An Peng. (2020). Diminution of Phagocytosed Micro/Nanoparticles by Tethering with Immunoregulatory CD200 Protein. Scientific Reports. 10(1). 8604–8604. 2 indexed citations
6.
Peng, Ching‐An, et al.. (2019). Enhanced proliferation and differentiation of mesenchymal stem cells by astaxanthin-encapsulated polymeric micelles. PLoS ONE. 14(5). e0216755–e0216755. 28 indexed citations
7.
Wang, Jie‐Sheng & Ching‐An Peng. (2011). Anticancer effectiveness of polymeric drug nanocarriers on colorectal cancer cells. PubMed. 79. 3249–3252. 9 indexed citations
8.
Chen, Yuhao, Chung‐Hao Wang, Chia‐Wei Chang, & Ching‐An Peng. (2010). In situ formation of viruses tagged with quantum dots. Integrative Biology. 2(5-6). 258–258. 9 indexed citations
9.
Peng, Ching‐An. (2009). Analysis of Gene Transfer Rate with Immobilized Retroviral Vectors. Annals of the New York Academy of Sciences. 1161(1). 26–33. 1 indexed citations
10.
Yacobi, Nazanin R., Harish C. Phuleria, Lucas DeMaio, et al.. (2007). Nanoparticle effects on rat alveolar epithelial cell monolayer barrier properties. Toxicology in Vitro. 21(8). 1373–1381. 60 indexed citations
11.
You, Jin‐Oh, Yu‐Chuan Liu, & Ching‐An Peng. (2006). Efficient gene transfection using chitosan ? alginate core-shell nanoparticles. International Journal of Nanomedicine. 1(2). 173–180. 47 indexed citations
12.
Kwon, Young Jik & Ching‐An Peng. (2005). High‐yield retroviral production using a temperature‐modulated two‐stage operation. Biotechnology and Bioengineering. 90(3). 365–372. 2 indexed citations
13.
You, Jin‐Oh & Ching‐An Peng. (2004). Phagocytosis‐mediated retroviral transduction: co‐internalization of deactivated retrovirus and calcium‐alginate microspheres by macrophages. The Journal of Gene Medicine. 7(4). 398–406. 13 indexed citations
14.
Kwon, Young Jik & Ching‐An Peng. (2003). Evaluation of Retroviral Production Systems Using Quantitative Analysis. Biotechnology Progress. 19(2). 528–537. 3 indexed citations
15.
Kwon, Young Jik & Ching‐An Peng. (2002). Engineering Analysis of Ex Vivo Retroviral Transduction System. Annals of Biomedical Engineering. 30(5). 731–742. 3 indexed citations
16.
Kwon, Young Jik & Ching‐An Peng. (2002). Transduction rate constant as more reliable index quantifying efficiency of retroviral gene delivery. Biotechnology and Bioengineering. 77(6). 668–667. 11 indexed citations
17.
Peng, Ching‐An & Yu‐Chih Hsu. (2001). FLUOROALKYLATED POLYETHYLENE GLYCOL AS POTENTIAL SURFACTANT FOR PERFLUOROCARBON EMULSION. Artificial Cells Blood Substitutes and Biotechnology. 29(6). 483–492. 9 indexed citations
18.
Hsu, Yu‐Chih & Ching‐An Peng. (2001). Diminution of Phagocytosed Perfluorocarbon Emulsions Using Perfluoroalkylated Polyethylene Glycol Surfactant. Biochemical and Biophysical Research Communications. 283(4). 776–781. 7 indexed citations
19.
Peng, Ching‐An, et al.. (2001). ENHANCEMENT OF MICROALGAL GROWTH BY USING PERFLUOROCARBON AS OXYGEN CARRIER. Artificial Cells Blood Substitutes and Biotechnology. 29(1). 47–55. 12 indexed citations
20.
Peng, Ching‐An & Bernhard Ø. Palsson. (2000). Cell growth and differentiation on feeder layers is predicted to be influenced by bioreactor geometry. Biotechnology and Bioengineering. 50(5). 479–492. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026